CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-06 | Paulson Richard A. President and CEO | Sale | −4,012 | $1.59 | $6K | 821,453 |
| 2024-01-24 | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Grant or award | +14,167 | 221,499 | ||
| 2024-01-24 | Rangwala Reshma EVP & Chief Medical Officer | Grant or award | +14,167 | 172,397 | ||
| 2024-01-24 | Poulton Stuart EVP, Chief Development Officer | Grant or award | +13,333 | 169,619 | ||
| 2024-01-24 | Mano Michael SVP, General Counsel&Secretary | Grant or award | +9,167 | 151,401 | ||
| 2024-01-24 | Mason Michael EVP, CFO & Treasurer | Grant or award | +13,333 | 251,150 | ||
| 2024-01-24 | Paulson Richard A. President and CEO | Grant or award | +42,000 | 825,465 | ||
| 2024-01-04 | Paulson Richard A. President and CEO | Sale | −4,114 | $0.82 | $3K | 783,465 |
| 2023-12-04 | Paulson Richard A. President and CEO | Sale | −3,622 | $0.79 | $3K | 787,579 |
| 2023-11-06 | Paulson Richard A. President and CEO | Sale | −3,606 | $0.92 | $3K | 791,201 |
| 2023-10-04 | Paulson Richard A. President and CEO | Sale | −3,589 | $1.27 | $5K | 794,807 |
| 2023-09-12 | BOHLIN GAREN G Director | Purchase | +41,140 | $1.22 | $50K | 45,140 |
| 2023-09-05 | Paulson Richard A. President and CEO | Sale | −3,558 | $1.33 | $5K | 798,460 |
| 2023-09-05 | Paulson Richard A. President and CEO | Sale | −64 | $1.32 | $84 | 798,396 |
| 2023-09-01 | Mason Michael EVP, CFO & Treasurer | Sale | −6,913 | $1.33 | $9K | 237,817 |
| 2023-09-01 | Mano Michael SVP, General Counsel&Secretary | Sale | −3,888 | $1.33 | $5K | 142,234 |
| 2023-09-01 | Cheng Sohanya Roshan EVP & Chief Commercial Officer | Sale | −7,415 | $1.33 | $10K | 204,086 |
| 2023-08-31 | Su Zhen Director | Grant or award · Nonstatutory Stock Option (right to buy) | +68,000 | 68,000 | ||
| 2023-08-07 | Paulson Richard A. President and CEO | Sale 10b5-1 | −3,722 | $1.72 | $6K | 802,018 |
| 2023-07-28 | Poulton Stuart EVP, Chief Development Officer | Sale 10b5-1 | −2,845 | $1.70 | $5K | 156,286 |
Page 9 of 15 · 287 trades